CHKA and cancer: Matrine and oxymatrine have been implicated as the primary active components for cancer treatment11, but this is not supported by our previous research that showed that CKI, but not oxymatrine, can inhibit cancer cell proliferation and cause apoptosis by perturbing the cell cycle and other cancer related pathways12–15.